PLK1 and neoplasm: For instance, LNPs encapsulating Cas9 mRNA and gRNAs targeting polo-like kinase 1 (PLK1) in a glioblastoma mouse model demonstrated effective gene editing and tumor suppression (Rosenblum et al., 2020).